4 Results for "

CH0793076

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CH0793076" in MCE Product Catalog:

Cat. No.: HY-107096
CAS No.: 534605-78-2
Synonyms: TP3076
Target:  

Topoisomerase

Research Areas:  

Cancer

CH-0793076 (TP3076), a hexacyclic camptothecin analog, is active drug and major metabolite of TP300. CH-0793076 inhibits DNA topoisomerase I with an IC50 of 2.3 μM. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein) .
loading...
    loading...
Cat. No.: HY-107096B
CAS No.: 2740278-76-4
Purity:  98.71%
Synonyms: TP3076 TFA
Target:  

Topoisomerase

Research Areas:  

Cancer

CH-0793076 (TP3076) TFA, a hexacyclic camptothecin analog, is active drug and major metabolite of TP300. CH-0793076 TFA inhibits DNA topoisomerase I with an IC50 of 2.3 μM. CH-0793076 TFA is efficacious against cells expressing BCRP (breast cancer resistance protein) .
loading...
    loading...
Cat. No.: HY-14833
CAS No.: 867063-97-6
Synonyms: TP300
Target:  

Topoisomerase

Research Areas:  

Cancer

Atiratecan (TP300) is a proagent of camptothecin analog CH0793076 (HY-107096). Atiratecan does not inhibit acetylcholinesterase (AChE) activities. Atiratecan shows antitumor activity against both breast cancer resistance protein (BCRP)-positive and -negative xenografts in mouse xenograft models .
loading...
    loading...
Cat. No.: HY-135845
CAS No.: 534605-74-8
Synonyms: CH0793011
Target:  

Topoisomerase

Research Areas:  

Cancer

TP3011 (CH0793011) is an active metabolite of CH-0793076 and is a potent topoisomerase I inhibitor equipotent as SN38 . TP3011 is against cancer cell lines growth with IC50s at the range sub-nanomolar in vitro .
loading...
    loading...